메뉴 건너뛰기




Volumn 37, Issue 4, 2014, Pages 427-434

Pharmacodynamic effects of adjunctive high dose atorvastatin on double dose clopidogrel in patients with high on-treatment platelet reactivity depending on diabetes mellitus status

Author keywords

Clopidogrel; Diabetes; High dose statins; VerifyNow assay

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ATORVASTATIN; CLOPIDOGREL; CREATININE; INSULIN; ANTITHROMBOCYTIC AGENT; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; TICLOPIDINE;

EID: 84899945598     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-0966-0     Document Type: Article
Times cited : (4)

References (36)
  • 1
    • 59849120163 scopus 로고    scopus 로고
    • Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: A 12-month follow-up
    • Marcucci R, Gori AM, Paniccia R et al (2009) Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up. Circulation 119:237-242
    • (2009) Circulation , vol.119 , pp. 237-242
    • Marcucci, R.1    Gori, A.M.2    Paniccia, R.3
  • 2
    • 80052167250 scopus 로고    scopus 로고
    • Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: A collaborative meta-analysis of individual participant data
    • Brar SS, ten Berg J, Marcucci M et al (2011) Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data. J Am Coll Cardiol 58:1945-1954
    • (2011) J Am Coll Cardiol , vol.58 , pp. 1945-1954
    • Brar, S.S.1    Ten Berg, J.2    Marcucci, M.3
  • 4
    • 84865694063 scopus 로고    scopus 로고
    • Antiplatelet therapy following myocardial infarction in patients with diabetes
    • Bhatt DL (2012) Antiplatelet therapy following myocardial infarction in patients with diabetes. JAMA 308:921-922
    • (2012) JAMA , vol.308 , pp. 921-922
    • Bhatt, D.L.1
  • 9
    • 79952168736 scopus 로고    scopus 로고
    • Diabetes and antiplatelet therapy in acute coronary syndrome
    • Jl Ferreiro, Angiolillo DJ (2011) Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation 123:798-813
    • (2011) Circulation , vol.123 , pp. 798-813
    • Ferreiro, Jl.1    Angiolillo, D.J.2
  • 10
    • 84869162101 scopus 로고    scopus 로고
    • Cardiovascular disease and diabetes: The vulnerable patients
    • Hess K, Marx N, Lehrke M (2012) Cardiovascular disease and diabetes: the vulnerable patients. Eur Heart J 14(suppl B):B4-B13
    • (2012) Eur Heart J , vol.14 , Issue.SUPPL. B
    • Hess, K.1    Marx, N.2    Lehrke, M.3
  • 11
    • 84865701469 scopus 로고    scopus 로고
    • Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes
    • Andersson C, Lyngbæk S, Nguyen CD et al (2012) Association of clopidogrel treatment with risk of mortality and cardiovascular events following myocardial infarction in patients with and without diabetes. JAMA 308:882-889
    • (2012) JAMA , vol.308 , pp. 882-889
    • Andersson, C.1    Lyngbæk, S.2    Nguyen, C.D.3
  • 12
    • 33847130538 scopus 로고    scopus 로고
    • Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: Results of the optimizing antiplatelet therapy in diabetes mellitus (OPTIMUS) study
    • DOI 10.1161/CIRCULATIONAHA.106.667741, PII 0000301720070213000008
    • Angiolillo DJ, Shoemaker SB, Desai B et al (2007) Randomized comparison of a high clopidogrel maintenance dose in patients with diabetes mellitus and coronary artery disease: results of the Optimizing Antiplatelet Therapy in Diabetes Mellitus (OPTIMUS) study. Circulation 115:708-716 (Pubitemid 46294761)
    • (2007) Circulation , vol.115 , Issue.6 , pp. 708-716
    • Angiolillo, D.J.1    Shoemaker, S.B.2    Desai, B.3    Yuan, H.4    Charlton, R.K.5    Bernardo, E.6    Zenni, M.M.7    Guzman, L.A.8    Bass, T.A.9    Costa, M.A.10
  • 13
    • 52449085759 scopus 로고    scopus 로고
    • A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: Results of the OPTIMUS-2 study
    • Angiolillo DJ, Capranzano P, Goto S et al (2008) A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study. Eur Heart J 29:2202-2211
    • (2008) Eur Heart J , vol.29 , pp. 2202-2211
    • Angiolillo, D.J.1    Capranzano, P.2    Goto, S.3
  • 14
    • 79952149001 scopus 로고    scopus 로고
    • A pharmacodynamic comparison of prasugrel vs. High-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: Results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial
    • Angiolillo DJ, Badimon JJ, Saucedo JF et al (2011) A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing anti-Platelet Therapy In diabetes MellitUS (OPTIMUS)-3 Trial. Eur Heart J 32:838-846
    • (2011) Eur Heart J , vol.32 , pp. 838-846
    • Angiolillo, D.J.1    Badimon, J.J.2    Saucedo, J.F.3
  • 15
    • 79961056489 scopus 로고    scopus 로고
    • Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy
    • Angiolillo DJ, Capranzano P, Ferreiro JL et al (2011) Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy. Thromb Haemost 106:253-262
    • (2011) Thromb Haemost , vol.106 , pp. 253-262
    • Angiolillo, D.J.1    Capranzano, P.2    Ferreiro, J.L.3
  • 16
    • 84871719026 scopus 로고    scopus 로고
    • Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: Impact of high on-treatment platelet reactivity and diabetes mellitus status
    • Capranzano P, Ferreiro JL, Ueno M et al (2013) Pharmacodynamic effects of adjunctive cilostazol therapy in patients with coronary artery disease on dual antiplatelet therapy: impact of high on-treatment platelet reactivity and diabetes mellitus status. Catheter Cardiovasc Interv 81:42-49
    • (2013) Catheter Cardiovasc Interv , vol.81 , pp. 42-49
    • Capranzano, P.1    Ferreiro, J.L.2    Ueno, M.3
  • 17
    • 55949103494 scopus 로고    scopus 로고
    • Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38
    • TRITON-TIMI 38 Investigators
    • Wiviott SD, Braunwald E, Angiolillo DJ, TRITON-TIMI 38 Investigators et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38. Circulation 118:1626-1636
    • (2008) Circulation , vol.118 , pp. 1626-1636
    • Wiviott, S.D.1    Braunwald, E.2    Angiolillo, D.J.3
  • 18
    • 78650368771 scopus 로고    scopus 로고
    • Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: A substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial
    • PLATO Study Group
    • James S, Angiolillo DJ, Cornel JH et al PLATO Study Group (2010) Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J 31:3006-3016
    • (2010) Eur Heart J , vol.31 , pp. 3006-3016
    • James, S.1    Angiolillo, D.J.2    Cornel, J.H.3
  • 19
    • 84860390388 scopus 로고    scopus 로고
    • Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel
    • Ueno M, Ferreiro JL, Tomasello SD et al (2011) Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. JACC Cardiovasc Interv 4:905-912
    • (2011) JACC Cardiovasc Interv , vol.4 , pp. 905-912
    • Ueno, M.1    Ferreiro, J.L.2    Tomasello, S.D.3
  • 20
    • 84870356894 scopus 로고    scopus 로고
    • Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
    • Suryadevara S, Ueno M, Tello-Montoliu A et al (2012) Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus. Thromb Haemost 108:930-936
    • (2012) Thromb Haemost , vol.108 , pp. 930-936
    • Suryadevara, S.1    Ueno, M.2    Tello-Montoliu, A.3
  • 21
    • 79955155110 scopus 로고    scopus 로고
    • Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo
    • Vivas D, García-Rubira JC, Bernardo E et al (2011) Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo"). Heart 97:803-809
    • (2011) Heart , vol.97 , pp. 803-809
    • Vivas, D.1    García-Rubira, J.C.2    Bernardo, E.3
  • 22
    • 18444374227 scopus 로고    scopus 로고
    • Clinical significance of statin pleiotropic effects hypotheses versus evidence
    • Davidson MH (2005) Clinical significance of statin pleiotropic effects hypotheses versus evidence. Circulation 111:2280-2281
    • (2005) Circulation , vol.111 , pp. 2280-2281
    • Davidson, M.H.1
  • 23
    • 84863613858 scopus 로고    scopus 로고
    • Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2
    • PignatelliP Carnevale R, Pastori D et al (2012) Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. Circulation 126:92-103
    • (2012) Circulation , vol.126 , pp. 92-103
    • Pignatelli, P.1    Carnevale, R.2    Pastori, D.3
  • 25
    • 84877728751 scopus 로고    scopus 로고
    • Impact of high dose atorvastatin on the pharmacodynamic effects of double dose clopidogrel in patients undergoing percutaneous coronary interventions: The ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study
    • Leoncini M, Toso A, Maioli M et al (2013) Impact of high dose atorvastatin on the pharmacodynamic effects of double dose clopidogrel in patients undergoing percutaneous coronary interventions: the ACHIDO (Atorvastatin and Clopidogrel HIgh DOse in stable patients with residual high platelet activity) study. JACC Cardiovasc Interv 6(2):169-179
    • (2013) JACC Cardiovasc Interv , vol.6 , Issue.2 , pp. 169-179
    • Leoncini, M.1    Toso, A.2    Maioli, M.3
  • 26
    • 77953911457 scopus 로고    scopus 로고
    • Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate
    • Bonello L, Tantry US, Marcucci R et al (2010) Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 56:919-933
    • (2010) J Am Coll Cardiol , vol.56 , pp. 919-933
    • Bonello, L.1    Tantry, U.S.2    Marcucci, R.3
  • 27
    • 84862992613 scopus 로고    scopus 로고
    • Pharmacogenetics of clopidogrel: Comparison between a standard and a rapid genetic testing
    • Saracini C, Vestrini A, Galora S et al (2012) Pharmacogenetics of clopidogrel: comparison between a standard and a rapid genetic testing. Genet Test Mol Biomarkers 16:500-503
    • (2012) Genet Test Mol Biomarkers , vol.16 , pp. 500-503
    • Saracini, C.1    Vestrini, A.2    Galora, S.3
  • 28
    • 62949165644 scopus 로고    scopus 로고
    • Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: A randomized, controlled study
    • Han Y, Li Y, Wang S et al (2009) Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study. Am Heart J 157:733-739
    • (2009) Am Heart J , vol.157 , pp. 733-739
    • Han, Y.1    Li, Y.2    Wang, S.3
  • 29
    • 77958571929 scopus 로고    scopus 로고
    • Pilot Study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity
    • Barker CM, Murray SS, Teirstein PS et al (2010) Pilot Study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to CYP2C19 genotype in patients with high on-treatment reactivity. J Am Coll Cardiol Intv 3:1001-1007
    • (2010) J Am Coll Cardiol Intv , vol.3 , pp. 1001-1007
    • Barker, C.M.1    Murray, S.S.2    Teirstein, P.S.3
  • 30
    • 79851480679 scopus 로고    scopus 로고
    • High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial and inflammation: Results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study
    • Patti G, Greco D, Dicuonzo G et al (2011) High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial and inflammation: results of the ARMYDA-150 mg (antiplatelet therapy for reduction of myocardial damage during angioplasty) randomized study. J Am Coll Cardiol 57:771-778
    • (2011) J Am Coll Cardiol , vol.57 , pp. 771-778
    • Patti, G.1    Greco, D.2    Dicuonzo, G.3
  • 31
    • 84861230787 scopus 로고    scopus 로고
    • The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial)
    • Ari H, Ozkan H, Karacinar A et al (2012) The EFFect of hIgh-dose ClopIdogrel treatmENT in patients with clopidogrel resistance (The EFFICIENT Trial). Int J Cardiol 157:374-380
    • (2012) Int J Cardiol , vol.157 , pp. 374-380
    • Ari, H.1    Ozkan, H.2    Karacinar, A.3
  • 32
    • 79952598836 scopus 로고    scopus 로고
    • Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: The GRAVITAS randomized trial
    • Investigators GRAVITAS
    • Price MJ, Berger PB, Teirstein PS, Investigators GRAVITAS et al (2011) Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA 305:1097-1105
    • (2011) JAMA , vol.305 , pp. 1097-1105
    • Price, M.J.1    Berger, P.B.2    Teirstein, P.S.3
  • 33
    • 84870032410 scopus 로고    scopus 로고
    • Bedside monitoring to adjust antiplatelet therapy for coronary stenting
    • Investigators ARCTIC
    • Collet JP, Cuisset T, Rangé G, Investigators ARCTIC et al (2012) Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367:2100-2109
    • (2012) N Engl J Med , vol.367 , pp. 2100-2109
    • Collet, J.P.1    Cuisset, T.2    Rangé, G.3
  • 34
    • 38049033935 scopus 로고    scopus 로고
    • Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: A meta-analysis
    • Cholesterol Treatment Trialists' (CTT) Collaborators
    • Cholesterol Treatment Trialists' (CTT) Collaborators (2008) Efficacy of cholesterol-lowering therapy in 18686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 371:117-125
    • (2008) Lancet , vol.371 , pp. 117-125
  • 35
    • 77955989559 scopus 로고    scopus 로고
    • Profiling induction of cytochrome P450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes
    • Feidt DM, Klein Kathrin et al (2010) Profiling induction of cytochrome P450 enzyme activity by statins using a new liquid chromatography-tandem mass spectrometry cocktail assay in human hepatocytes. Drug Metab Dispos 38:1589-1597
    • (2010) Drug Metab Dispos , vol.38 , pp. 1589-1597
    • Feidt, D.M.1    Klein, K.2
  • 36
    • 77950555307 scopus 로고    scopus 로고
    • Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: The OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study
    • Gajos G, Rostoff P, Undas A et al (2010) Effects of polyunsaturated omega-3 fatty acids on responsiveness to dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: the OMEGA-PCI (OMEGA-3 fatty acids after pci to modify responsiveness to dual antiplatelet therapy) study. J Am Coll Cardiol 55:1671-1678
    • (2010) J Am Coll Cardiol , vol.55 , pp. 1671-1678
    • Gajos, G.1    Rostoff, P.2    Undas, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.